Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Boehringer Ingelheim
Queensland Health
Chubb
Chinese Patent Office
Fuji

Generated: July 23, 2019

DrugPatentWatch Database Preview

Patent: 8,545,843

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,545,843
Title:Treatment of vasculitis
Abstract: The present invention concerns treatment of autoimmune diseases with antagonists which bind to B cell surface markers, such as CD19 or CD20.
Inventor(s): Curd; John G. (Hillsborough, CA), Grillo-Lopez; Antonio J. (San Diego, CA)
Assignee: Genentech, Inc. (South San Francisco, CA) Biogen Idec Inc. (Cambride, MA)
Application Number:12/886,171
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,545,843
Patent Claims:see list of patent claims

Details for Patent 8,545,843

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26 ➤ Sign Up Genentech, Inc. (South San Francisco, CA) Biogen Idec Inc. (Cambride, MA) ➤ Sign Up RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chubb
Argus Health
Johnson and Johnson
Chinese Patent Office
Accenture

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.